Heritage Cannabis acquires of Opticann
On October 7, 2020, Heritage Cannabis Holdings Corp. ("Heritage") announced the completion of its acquisition of all of the issued and outstanding shares of Opticann, Inc. ("Opticann"), a Colorado-based oral and topical cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb® drug delivery system for optimized absorption and stability. Opticann was acquired in exchange for common shares of Heritage, including shares that may be issued upon the achievement of various milestones.
Further information can be found on Business Wire's website.
Opticann, founded by former MedReleaf executives, is a Colorado-based oral and topical cannabinoid company with the rights to exclusively sell CBD and CBG products made with the patented VESIsorb® drug delivery system for optimized absorption and stability.
Heritage Cannabis is a vertically integrated cannabis provider that currently has two Health Canada approved licenced producers, through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. both regulated under the Cannabis Act Regulations.